Skip to main content
SpringerLink
Log in

Pembrolizumab

Pseudomembranous aspergillus tracheobronchitis and rhinovirus infection: case report

Reactions Weekly volume 1686, page 288 (2018)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Reference

  • Sequeira H, et al. Pseudomembranous aspergillus tracheobronchitis as a complication of PD-L1 inhibitor therapy. Critical Care Medicine 46 (Suppl.): 301 abstr. 630, No. 1, 01 Jan 2018. Available from: URL: http://doi.org/10.1097/01.ccm.0000528645.28636.b8 [abstract] - USA

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pembrolizumab. Reactions Weekly 1686, 288 (2018). https://doi.org/10.1007/s40278-018-41351-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41351-2

search

Navigation